Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Scienture Holdings ( (SCNX) ) has shared an update.
On October 24, 2025, Scienture Holdings, Inc. filed a prospectus supplement with the SEC to increase the amount of its common stock eligible for sale under a previous agreement with Maxim Group LLC, aiming for an aggregate offering price of up to $9,592,009. The company has already sold approximately $13,252,250 in securities over the past 12 months, leaving $9,592,009 available for future sale, which could impact its financial strategy and market presence.
The most recent analyst rating on (SCNX) stock is a Sell with a $2.00 price target. To see the full list of analyst forecasts on Scienture Holdings stock, see the SCNX Stock Forecast page.
Spark’s Take on SCNX Stock
According to Spark, TipRanks’ AI Analyst, SCNX is a Underperform.
Scienture Holdings faces significant challenges with weak financial performance and concerning valuation metrics. High volatility and recent corporate events contribute to the risk profile despite some short-term technical momentum.
To see Spark’s full report on SCNX stock, click here.
More about Scienture Holdings
Average Trading Volume: 16,360,703
Technical Sentiment Signal: Strong Sell
Current Market Cap: $31.46M
For an in-depth examination of SCNX stock, go to TipRanks’ Overview page.

